
Accuray (ARAY) Stock Forecast & Price Target
Accuray (ARAY) Analyst Ratings
Bulls say
Accuray is experiencing increased investor sentiment due to improved growth and profitability, leading to a positive outlook. With a $4 price target based on a 1.5x EV/Sales multiple on the 12-24 month revenue estimate and the goal of a DD margin in the medium to long-term, the company is expected to see significant returns in the future through the CyberKnife and TomoTherapy platforms.
Bears say
Accuray is projected to experience a weak financial year with lower revenue and product margins due to the impact of US-China tariffs, geopolitical tensions, and product mix. With a 1.1x book-to-bill ratio in the first quarter and a 1.5x ratio in the second, there is uncertainty about the company's ability to convert orders to revenue, and risks such as supply chain challenges and potential dilution further dampen the outlook. Additionally, the company's reliance on improving service revenue to offset weak product revenue is another factor contributing to the negative outlook.
This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.
Accuray (ARAY) Analyst Forecast & Price Prediction
Start investing in Accuray (ARAY)
Order type
Buy in
Order amount
Est. shares
0 shares